Meeting Summary: Global Vaccine and Immunization Research Forum, 2021

Ford, Alexander C; Hwang, Angela; Mo, Annie X.; Baqar, Shahida; Touchette, Nancy; Deal, Carolyn D.; King, Deborah; Earle, Kristen A.; Giersing, Birgitte; Dull, Peter; Hall, Bradford

doi:10.1016/j.vaccine.2023.02.028

Cited by 7 publications

(27 citation statements)

References 51 publications

(52 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most frequently discussed topics within the 22 publications addressing this element were access to services and resources, and equity in access ( Table 1 ). 18 , 20 , 23 , 30 , 33 , 37 , 42 – 47 , 49 , 51 , 59 , 61 , 63 , 69 , 70 , 72 , 76 , 77 The literature is focused on the need for cohesive and equitable strategies in pandemic preparedness and response, highlighting the importance of integrating global health security into UHC with an emphasis on human rights, equity and social determinants of health. A crucial topic is the need to understand the treatment of pandemic technologies, such as vaccines, as common goods, focusing on equity and knowledge sharing.…”

Section: Resultsmentioning

confidence: 99%

“…Notably, 19 of these 22 articles also discuss topics within the infrastructure and system element. 18 , 30 , 33 , 37 , 42 , 43 , 45 – 47 , 49 , 51 , 59 , 61 , 63 , 69 , 70 , 72 , 76 , 77 This overlap includes discussions on financing systems and structures, public–private partnerships in research and development, and global health systems and security.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Financing for pandemic preparedness and response measures: a systematic scoping review

Duran-Fernandez,

Bernal-Serrano,

Garcia-Huitron

et al. 2024

Bull World Health Organ

View full text Add to dashboard Cite

Objective To obtain insights into reducing the shortfall in financing for pandemic preparedness and response measures, and reducing the risk of another pandemic with social and economic costs comparable to those of the coronavirus disease. Methods We conducted a systematic scoping review using the databases ScienceDirect, Scopus, JSTOR, PubMed® and EconLit. We included articles published in any language until 1 August 2023, and excluded grey literature and publications on epidemics. We categorized eligible studies according to the elements of a framework proposed by the World Health Organization Council on the Economy of Health for All: (i) root/structural causes; (ii) social position/foundations; (iii) infrastructure and systems; and (iv) communities, households and individuals. Findings Of the 188 initially identified articles, we included 60 in our review. Most (53/60) were published after 2020, when academic interest had shifted towards global financing mechanisms. Most (37/60) addressed two or more of the council framework elements. The most frequently addressed element was infrastructure and systems (54/60), discussing topics such as health systems, financial markets and innovation ecosystems. The roots/structural causes were discussed in 25 articles; communities, households and individuals in 22 articles; and social positions/foundations in 11. Conclusion Our review identified three important gaps: a formal definition of pandemic preparedness and response, impeding the accurate quantification of the financing shortfall; research on the extent to which financing for pandemic preparedness and response has been targeted at the most vulnerable households; and an analysis of specific financial instruments and an evaluation of the feasibility of their implementation.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Financing for pandemic preparedness and response measures: a systematic scoping review

Duran-Fernandez,

Bernal-Serrano,

Garcia-Huitron

et al. 2024

Bull World Health Organ

View full text Add to dashboard Cite

show abstract

“…The severe acute respirarory syndrome (SARS) and Middle East respiratory syndrome (MERS) outbreaks ended before the development of vaccines for each disease; vaccine development for Ebola disease progressed relatively slowly over several years, while COVID-19 spread rapidly worldwide and the vaccine development process for COVID-19 progressed quicker compared to the previous vaccine development for new infectious diseases. 10 11 12 In the past, it took decades to develop a vaccine after the causative agent of infectious diseases was identified; however, in COVID-19, vaccines were expeditiously developed and approved for emergency use within a year after the causative virus was identified. 12 …”

Section: Introductionmentioning

confidence: 99%

“… 10 11 12 In the past, it took decades to develop a vaccine after the causative agent of infectious diseases was identified; however, in COVID-19, vaccines were expeditiously developed and approved for emergency use within a year after the causative virus was identified. 12 …”

Section: Introductionmentioning

confidence: 99%

Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19

Wie,

Jung,

Kim

2023

J Korean Med Sci

View full text Add to dashboard Cite

Social isolation and control owing to coronavirus disease 2019 (COVID-19) are easing; however, concerns regarding new infectious diseases have not disappeared. Given epidemic experiences such as severe acute respiratory syndrome (SARS), the influenza pandemic, Middle East respiratory syndrome (MERS), and COVID-19, it is necessary to prepare for the outbreak of new infectious diseases and situations in which large-scale vaccinations are required. Although the development of vaccines against COVID-19 has contributed greatly to overcoming the pandemic, concerning vaccine side effects from the general public, including medical personnel, and decreased confidence in vaccine efficacy and side effects, present many challenges in promoting and educating vaccinations for new infectious diseases in the future. In addition to plans to develop vaccines for the outbreak of new infectious diseases, education and promotion plans are necessary to administer the latest developments of vaccines to the general public. Moreover, efforts are needed to secure the necessity, legitimacy, and evidence for rapid vaccination on a large scale at the national level. It is also necessary to carefully prepare scientific bases and explanatory statements so that the general public can easily understand them. This study aimed to establish vaccine strategies and vaccination education plans for new infectious diseases that may occur in the future. Many ways to promote vaccination to the general public and healthcare workers should be prepared to ensure that the latest vaccines against new infectious diseases are administered safely. Thus, education and promotion of vaccine efficacy and safety based on specific data from clinical studies are necessary.

show abstract

“…Despite commitments to develop an mRNA vaccine domestically, progress has been sluggish, and even with some production, these vaccines have not been fully integrated into clinical practice. Reflecting on the historical trajectory of vaccine development, including both triumphs and setbacks as seen with COVID-19 [ 5 ], it is imperative to identify bottlenecks preventing vaccines from reaching the field in order to better prepare for future outbreaks and national health security threats.…”

mentioning

confidence: 99%

What are the strategies for national health security in preparation for the next pandemic?

Lee

2024

PHRP

View full text Add to dashboard Cite

Meeting Summary: Global Vaccine and Immunization Research Forum, 2021

Cited by 7 publications

References 51 publications

Financing for pandemic preparedness and response measures: a systematic scoping review

Financing for pandemic preparedness and response measures: a systematic scoping review

Effective Vaccination and Education Strategies for Emerging Infectious Diseases Such as COVID-19

What are the strategies for national health security in preparation for the next pandemic?

Contact Info

Product

Resources

About